News Filter by: Industry Team Airport & AviationAutomotiveEnergyFood & Beverage Health CareHospitality & LeisureInsurance & ReinsuranceLife Sciences ManufacturingSportsTechnology Practice Area Corporate All CorporateEmployee Benefits & Executive CompensationEnvironmentalEstates & TrustsFinance Private Equity & Venture CapitalReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactions Government Solutions All Government SolutionsExport Controls & National SecurityFDA RegulatoryFederal & State Energy RegulatoryFreight & Commuter RailGovernment Procurement Immigration, Nationality & Consular LawNHTSA & Motor Vehicle SafetyPolitical LawPublic PolicyStrategic Communications Intellectual Property All Intellectual PropertyBusiness Method & Software PatentsChemical, Biotechnology & PharmaceuticalCybersecurityElectronicsGreen Energy TechnologiesIP Asset Management IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTechnology Transactions & OutsourcingTrademark, Copyright & Advertising Counseling International All InternationalChinaEurope IsraelJapanMexico Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Law, Finance & Class Action Distribution & FranchiseGovernment Enforcement Defense & InvestigationsInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & LitigationTrade Secret Noncompete Litigation Office AustinBostonChicagoDallasDetroitJacksonvilleLos Angeles MadisonMexico CityMiamiMilwaukeeNew YorkOrlandoSacramento San DiegoSan FranciscoSilicon ValleyTallahasseeTampaTokyoWashington, D.C. Topic Big DataCuba Foreign Corrupt Practices Act (FCPA)Health Care Reform Telemedicine In the News Press Releases Media Contact Jill Chanen Public Relations Manager jchanen foley.com 312.832.4745 1234next 15 May 2018 Rosen Comments on Proposed Changes in FDA Drug-Device Rules –Bloomberg Law Partner David Rosen is quoted in a Bloomberg Law article, “Drug-Device Rules Could Give FDA Leg Up in Industry Fights,” about the FDA’s plan to revamp its rules on how to deal with overlapping drug, device and biologic products. 26 April 2018 Koski Comments on Prospects for Prescription Drug Legislation –Pharmaceutical Technology Partner Katy Koski was quoted in a Pharmaceutical Technology article, “CREATES Act Dropped But May Still See Progress,” about the chances that legislation aimed at lowering the costs of prescription drugs will be taken up by Congress this year. 29 December 2017 Beaver Addresses FDA’s Planned New Guidance for Drug Developers –BNA Health Care Blog Partner Nathan Beaver was quoted in a BNA Health Care Blog article, ”FDA to Provide Earlier, Better Advice to Drug Developers,” about the FDA’s efforts to enhance its communications with drug suppliers as a way of lowering the cost of drug development. 15 December 2017 Brinckerhoff Discusses Recent Federal Circuit Decision on Biosimilar with Bloomberg Law –Bloomberg Law Patent, Trademark & Copyright Journal - Daily Edition Partner Courtenay Brinckerhoff was quoted in a Bloomberg Law Patent, Trademark & Copyright Journal – Daily Edition article, “Biosimilars Statute Trumps State Law, Appeals Court Rules,” about a recent U.S. Court of Appeals for the Federal Circuit ruling on the Biologics Price Competition and Innovation Act. 28 November 2017 Rosen Comments on FDA Commissioner’s Remarks –Pink Sheet Partner David Rosen is quoted in a Pink Sheet article, “Gottlieb’s Complex Generics Remarks Could Signal (Some) Increased Flexibility,” about FDA Commissioner Scott Gottlieb’s remarks on generic copies of products with drug and device constituent parts at an internal FDA event for agency scientists and researchers. 15 November 2017 Foley Survey Shows Surging Telemedicine Services Across the Health Care Spectrum, into Foreign Markets Foley’s 2017 Telemedicine and Digital Health Survey reflects a surging demand for telemedicine-based offerings among providers and patients, and a broader acceptance of the technology by other major players in the health care industry. 01 November 2017 Foley Receives 27 National Tier 1 Practice Rankings by 2018 U.S. News – Best Lawyers –U.S. News - Best Lawyers Foley announced today that it received 27 national Tier 1 rankings and 113 metropolitan Tier 1 rankings in the 2018 edition of U.S. News – Best Lawyers “Best Law Firms.” 04 October 2017 Eppen Comments on Future of Recreational Marijuana Law in Massachusetts –Law360 Partner Ron Eppen is quoted in a Law360 article, “A Guide to Marijuana Legalization in Massachusetts,” about the implementation of a new law legalizing the recreational use of marijuana. 15 August 2017 Foley Attorneys Recognized in The Best Lawyers in America 2018 List –Best Lawyers Foley announced today that 25 attorneys earned Best Lawyers® 2018 “Lawyer of the Year” recognition in their respective practice areas, receiving the top nod from Best Lawyers. 31 July 2017 Government & Public Policy Attorney Kyle Faget Joins Foley Kyle Faget has joined Foley & Lardner LLP’s Government & Public Policy Practice Group as special counsel in the Boston office. She has also joined the firm’s Health Care and Life Sciences Industry Teams. 1234next Search News Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared
15 May 2018 Rosen Comments on Proposed Changes in FDA Drug-Device Rules –Bloomberg Law Partner David Rosen is quoted in a Bloomberg Law article, “Drug-Device Rules Could Give FDA Leg Up in Industry Fights,” about the FDA’s plan to revamp its rules on how to deal with overlapping drug, device and biologic products.
26 April 2018 Koski Comments on Prospects for Prescription Drug Legislation –Pharmaceutical Technology Partner Katy Koski was quoted in a Pharmaceutical Technology article, “CREATES Act Dropped But May Still See Progress,” about the chances that legislation aimed at lowering the costs of prescription drugs will be taken up by Congress this year.
29 December 2017 Beaver Addresses FDA’s Planned New Guidance for Drug Developers –BNA Health Care Blog Partner Nathan Beaver was quoted in a BNA Health Care Blog article, ”FDA to Provide Earlier, Better Advice to Drug Developers,” about the FDA’s efforts to enhance its communications with drug suppliers as a way of lowering the cost of drug development.
15 December 2017 Brinckerhoff Discusses Recent Federal Circuit Decision on Biosimilar with Bloomberg Law –Bloomberg Law Patent, Trademark & Copyright Journal - Daily Edition Partner Courtenay Brinckerhoff was quoted in a Bloomberg Law Patent, Trademark & Copyright Journal – Daily Edition article, “Biosimilars Statute Trumps State Law, Appeals Court Rules,” about a recent U.S. Court of Appeals for the Federal Circuit ruling on the Biologics Price Competition and Innovation Act.
28 November 2017 Rosen Comments on FDA Commissioner’s Remarks –Pink Sheet Partner David Rosen is quoted in a Pink Sheet article, “Gottlieb’s Complex Generics Remarks Could Signal (Some) Increased Flexibility,” about FDA Commissioner Scott Gottlieb’s remarks on generic copies of products with drug and device constituent parts at an internal FDA event for agency scientists and researchers.
15 November 2017 Foley Survey Shows Surging Telemedicine Services Across the Health Care Spectrum, into Foreign Markets Foley’s 2017 Telemedicine and Digital Health Survey reflects a surging demand for telemedicine-based offerings among providers and patients, and a broader acceptance of the technology by other major players in the health care industry.
01 November 2017 Foley Receives 27 National Tier 1 Practice Rankings by 2018 U.S. News – Best Lawyers –U.S. News - Best Lawyers Foley announced today that it received 27 national Tier 1 rankings and 113 metropolitan Tier 1 rankings in the 2018 edition of U.S. News – Best Lawyers “Best Law Firms.”
04 October 2017 Eppen Comments on Future of Recreational Marijuana Law in Massachusetts –Law360 Partner Ron Eppen is quoted in a Law360 article, “A Guide to Marijuana Legalization in Massachusetts,” about the implementation of a new law legalizing the recreational use of marijuana.
15 August 2017 Foley Attorneys Recognized in The Best Lawyers in America 2018 List –Best Lawyers Foley announced today that 25 attorneys earned Best Lawyers® 2018 “Lawyer of the Year” recognition in their respective practice areas, receiving the top nod from Best Lawyers.
31 July 2017 Government & Public Policy Attorney Kyle Faget Joins Foley Kyle Faget has joined Foley & Lardner LLP’s Government & Public Policy Practice Group as special counsel in the Boston office. She has also joined the firm’s Health Care and Life Sciences Industry Teams.